Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3

1. Slamon, D.J.
2. Neven, P.
3. Chia, S.
4. Fasching, P.A.
5. De Laurentiis, M.
6. Im, S.-A.
7. Petrakova, K.
8. Val Bianchi, G.
9. Esteva, F.J.
10. Martín, M.
11. Nusch, A.
12. Sonke, G.S.
13. De La Cruz-Merino, L.
14. Beck, J.T.
15. Pivot, X.
16. Vidam, G.
17. Wang, Y.
18. Lorenc, K.R.
19. Miller, M.
20. Taran, T.
21. Jerusalem, G.